Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.

Subject: Liver Disease - PUBLISHED VIA PLOS ONE

Author(s):
Hegde VL, Nagarkatti PS, Nagarkatti M

Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States of America

 View Source >>

Related Studies:

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.

Published via British Journal of Pharmacology

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Published via Author Manuscript

Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.

Published via European Journal of Pharmacology

The endocannabinoid system and liver diseases.

Published via Journal of Neuroendocrinology

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.

Published via Cell Death & Disease

View all medical studies

Learn More About Cannabis